-
Mashup Score: 0
The phase 3 MECCA trial represents the largest data set investigating the efficacy of metronomic chemo-endocrine combination therapy in metastatic breast cancer, according to researchers.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3
A growing body of research suggests that exposure to PFAS, commonly called “forever chemicals,” may increase a person’s risk of developing cancer.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
With @max_aung of @USC, Dr Kyle Steenland of @EmoryRollins, Dr Ned Colange of @ColoradoSPH, Dr Katherine Reeves of @UMassSPHHS, @kepelch of @NRDC, and @TraceyJWoodruff of @UCSF. https://t.co/ztmnzWEyPI
-
-
Mashup Score: 0“I Thought He Was Helping Me”: Patient Endured 9 Years of Chemotherapy for Cancer He Never Had - 2 day(s) ago
Oncologist Thomas C. Weiner misdiagnosed Anthony Olson with MDS in 2011. Olson is one of many patients who may have received unnecessary and harmful treatments after being misdiagnosed by Weiner.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Oncologist Thomas C. Weiner misdiagnosed Anthony Olson with #MDS in 2011. https://t.co/bCqw7I4Txy
-
-
Mashup Score: 2
Male AYA cancer survivors “experience many challenges related to fertility and reproductive health,” according to researchers.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Male survivors of #AYAcancers are more likely than men without a cancer history to have children born prematurely and at a low birth weight. Published in @JNCI_Now. https://t.co/rJnDBJvwgo
-
-
Mashup Score: 0Incidence of Testicular Germ Cell Tumors Rising in the US - 5 day(s) ago
Hispanic patients had the greatest average annual percent change in testicular germ cell tumor incidence.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The incidence of testicular germ cell #tumors is on the rise in the United States, particularly among Hispanic patients. Published in @JournalCancer. https://t.co/EqD4g6DEir #gucsm
-
-
Mashup Score: 0
Researchers noted that the safety and effectiveness of standard therapies for Merkel cell carcinoma “remains poorly studied.”
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Adjuvant radiotherapy can improve outcomes in patients with early-stage #MerkelCellCarcinoma. Published in @CancerMedicineJ. https://t.co/FkOTmyf3xr #skcsm
-
-
Mashup Score: 0Cuts to Medicare Physician Reimbursement Take Effect After Congress Fails to Pass Legislation - 7 day(s) ago
“For the fifth consecutive year, Congress has adjourned and allowed Medicare cuts,” said Bruce A. Scott, MD, president of the AMA.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Cuts to #Medicare physician reimbursement have taken effect, as proposed legislation intended to eliminate those cuts did not pass. https://t.co/iAuGVRgm3V
-
-
Mashup Score: 0
Adding durvalumab and bevacizumab to transarterial chemoembolization improved responses and progression-free survival.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Durvalumab plus bevacizumab and TACE could become a new standard of care for patients with unresectable #hepatocellularCarcinoma, according to researchers. From @TheLancet. https://t.co/ZtWt9I4R73 #hccsm #gicsm
-
-
Mashup Score: 0Brain Radiotherapy Plus Chemoimmunotherapy Shows Promise for NSCLC With Brain Metastases - 9 day(s) ago
The combination of brain radiotherapy and chemoimmunotherapy “resulted in promising intracranial and systemic anti-tumor activity, with a manageable safety profile,” researchers wrote.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The combination of brain radiotherapy and chemoimmunotherapy could be a treatment option for patients with non-small cell #lungcancer and brain metastases, according to researchers. Reported in @TheLancetOncol. https://t.co/hzxgF26bE3 #NSCLC #lcsm
-
-
Mashup Score: 0
A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Allo-HSCT consolidation improved LFS when compared to other consolidation regimens in older patients with AML in CR1. Findings published in @Haematologica. https://t.co/jeOiL7w59r #leusm #amlsm
-
Adding metronomic capecitabine to first-line treatment with an aromatase inhibitor improved outcomes in patients with HR-positive, HER2-negative metastatic #breastCancer. Published in @JCO_ASCO. https://t.co/prNUUcMr7A #bcsm